181 related articles for article (PubMed ID: 38002329)
21. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells.
Patel J; Amrutiya J; Bhatt P; Javia A; Jain M; Misra A
J Microencapsul; 2018 Mar; 35(2):204-217. PubMed ID: 29542378
[TBL] [Abstract][Full Text] [Related]
22. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy.
Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z
Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837
[TBL] [Abstract][Full Text] [Related]
23. Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles.
Colzani B; Pandolfi L; Hoti A; Iovene PA; Natalello A; Avvakumova S; Colombo M; Prosperi D
Int J Nanomedicine; 2018; 13():957-973. PubMed ID: 29491709
[TBL] [Abstract][Full Text] [Related]
24. Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma.
Lee HW; Seo HS; Yeom SY; Kim SN; Kim CR; Park DH; Park W; Choy YB; Park CG; Seo SI
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293494
[TBL] [Abstract][Full Text] [Related]
25. Transferrin decorated PLGA encumbered moxifloxacin nanoparticles and
Reddy GA; Handa M; Garabadu D; Kumar R; Kushawaha PK; Shukla R
Drug Dev Ind Pharm; 2023 Jan; 49(1):129-138. PubMed ID: 36852720
[TBL] [Abstract][Full Text] [Related]
26. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.
Karra N; Nassar T; Ripin AN; Schwob O; Borlak J; Benita S
Small; 2013 Dec; 9(24):4221-36. PubMed ID: 23873835
[TBL] [Abstract][Full Text] [Related]
27. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
Ye Z; Zhang Y; Liu Y; Liu Y; Tu J; Shen Y
Int J Nanomedicine; 2021; 16():2443-2459. PubMed ID: 33814909
[TBL] [Abstract][Full Text] [Related]
28. Improving cellular uptake and cytotoxicity of chitosan-coated poly(lactic-
Van Hees S; Elbrink K; De Schryver M; Delputte PL; Kiekens F
Nanomedicine (Lond); 2020 Nov; 15(27):2671-2688. PubMed ID: 33112210
[No Abstract] [Full Text] [Related]
29. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
30. Folate Decorated Multifunctional Biodegradable Nanoparticles for Gastric Carcinoma Active Targeting Theranostics.
Zhang X; Yan R; Wei Z; Yang D; Hu Z; Zhang Y; Huang X; Huang H; Wang W
Int J Nanomedicine; 2022; 17():2493-2502. PubMed ID: 35669001
[TBL] [Abstract][Full Text] [Related]
31. Surface Modification of Nanoparticles Enhances Drug Delivery to the Brain and Improves Survival in a Glioblastoma Multiforme Murine Model.
Wiwatchaitawee K; Ebeid K; Quarterman JC; Naguib Y; Ali MY; Oliva C; Griguer C; Salem AK
Bioconjug Chem; 2022 Nov; 33(11):1957-1972. PubMed ID: 35041398
[TBL] [Abstract][Full Text] [Related]
32. Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
Maya S; Sarmento B; Lakshmanan VK; Menon D; Jayakumar R
J Biomed Nanotechnol; 2014 Aug; 10(8):1416-28. PubMed ID: 25016642
[TBL] [Abstract][Full Text] [Related]
33. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
34. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer.
Vangara KK; Liu JL; Palakurthi S
Anticancer Res; 2013 Jun; 33(6):2425-34. PubMed ID: 23749891
[TBL] [Abstract][Full Text] [Related]
36. Investigating the Effect of Surface Hydrophilicity on the Destiny of PLGA-Poloxamer Nanoparticles in an In Vivo Animal Model.
Silvestri T; Grumetto L; Neri I; De Falco M; Graziano SF; Damiano S; Giaquinto D; Maruccio L; de Girolamo P; Villapiano F; Ciarcia R; Mayol L; Biondi M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833971
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, physicochemical characterization, and in vitro evaluation of biodegradable PLGA nanoparticles entrapped to folic acid for targeted delivery of kaempferitrin.
Govindarasu M; Abirami P; Alharthi SS; Thiruvengadam M; Rajakumar G; Vaiyapuri M
Biotechnol Appl Biochem; 2022 Dec; 69(6):2387-2398. PubMed ID: 35020231
[TBL] [Abstract][Full Text] [Related]
38. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells.
Sharma A; Hawthorne S; Jha SK; Jha NK; Kumar D; Girgis S; Goswami VK; Gupta G; Singh S; Dureja H; Chellappan DK; Dua K
Nanomedicine (Lond); 2021 Aug; 16(20):1763-1773. PubMed ID: 34296625
[No Abstract] [Full Text] [Related]
39. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
40. Spermidine-mediated poly(lactic-
Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J
Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]